9999999995-17-003038.txt : 20171122 9999999995-17-003038.hdr.sgml : 20171122 20171122001511 ACCESSION NUMBER: 9999999995-17-003038 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171121 DATE AS OF CHANGE: 20171122 EFFECTIVENESS DATE: 20171121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acer Therapeutics Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760333165 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-208314 FILM NUMBER: 171218285 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE #2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (844) 902-6100 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE #2240 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Opexa Therapeutics, Inc. DATE OF NAME CHANGE: 20060616 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2017-11-21 0001654954-17-010672 POS AM 0001069308 Acer Therapeutics Inc. 333-208314